Basic Study
Copyright ©The Author(s) 2023.
World J Methodol. Sep 20, 2023; 13(4): 223-237
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.223
Table 1 Correlation of Ras suppressor 1 expression and prognosis in gastric cancer with various clinicopathological factors
OS (631)
FP (522)
PPS (384)
n
HR
P value
n
HR
P value
n
HR
P value
Sex
Female1871.88 (1.22-2.89)c1791.65 (1.09-2.51)a1271.99 (1.21-3.25)b
Male3491.36 (0.94-1.97)0.0983411.4 (0.98-2.01)0.0642561.52 (1.09-2.14)a
Stage
I622.84 (0.63-12.88)0.16602.7 (0.6-12.26)0.18312.79 (0.53-14.68)0.21
II1351.47 (0.79-2.75)0.221310.73 (0.4-1.32)0.291052.01 (1.04-3.9)a
III1971.27 (0.87-1.87)0.221861.51 (1.02-2.22)a1421.2 (0.77-1.86)0.42
IV1401.53 (0.95-2.46)0.0781411.17 (0.74-1.84)0.511041.79 (1.13-2.83)a
T
T22411.64 (0.98-2.73)0.0552391.42 (0.88-2.29)0.151961.57 (0.9-2.72)0.11
T32041.3 (0.92-1.83)0.142041.36 (0.95-1.94)0.0911501.36 (0.93-1.99)0.12
T4383.33 (1.12-9.96)a392.12 (0.85-5.3)0.1294.68 (1.34-16.32)b
N
N0742.77 (1.19-6.43)a722.69 (1.16-6.23)a4110.98 (2.7-44.62)c
N1-34221.54 (1.18-2.01)b4231.35 (1.04-1.74)a3371.64 (1.22-2.19)c
M
M04441.72 (1.2-2.47)b4431.63 (1.16-2.31)b3421.77 (1.31-2.4)c
M1561.84 (1.02-3.29)a561.44 (0.79-2.6)0.23562.09 (0.98-4.45)0.052
HER2 status
Negative4291.46 (1.12-1.91)b4291.55 (1.06-2.26)a2831.79 (1.28-2.5)c
Positive2021.41 (0.95-2.09)0.0861661.46 (0.9-2.38)0.131011.46 (0.89-2.4)0.14
Treatment
Surgery alone3801.44 (1.07-1.93)a3751.36 (0.97-1.9)0.0712771.82 (1.31-2.52)c
5-FU-based adjuvant341.77 (0.69-4.52)0.23341.8 (0.77-4.25)0.17210.39 (0.13-1.18)0.085
Other adjuvant762.65 (1.09-6.4)a803.46 (1.03-11.67)a742.5 (0.98-6.41)a
Table 2 Correlation between Ras suppressor 1 level and immune cell biomarkers in gastrointestinal cancers
Immune cellBiomarkerCOAD
STAD
GBM
None
Purity
None
Purity
None
Purity
Cor
P value
Cor
P value
Cor
P value
Cor
P value
Cor
P value
Cor
P value
CD8+ T cellCD8A0.0522.64E-010.0088.73E-010.306c0.305c-0.056 4.90E-01-0.026 7.62E-01
CD8B-0.0433.60E-01-0.0761.25E-010.158b0.151b-0.157 5.30E-02-0.124 1.50E-01
T cellCD3D0.0344.72E-01-0.0098.63E-010.23c0.228c-0.140 8.37E-02-0.114 1.86E-01
CD3E0.123b0.099a0.248c0.245c-0.042 6.06E-010.007 9.38E-01
CD20.176c0.168c0.304c0.307c-0.074 3.61E-01-0.034 6.96E-01
B cellCD190.116a0.099a0.183c0.161b0.019 8.14E-01-0.047 5.86E-01
CD79A0.197c0.18c0.18c0.155b0.093 2.55E-010.133 1.21E-01
MonocyteCD860.255c0.258c0.361c0.375c0.024 7.72E-010.104 2.28E-01
CD115 (CSF1R)0.189c0.176c0.439c0.44c0.200 a0.302 c
TAMCCL20.352c0.337c0.348c0.355c0.034 6.74E-010.083 3.35E-01
CD680.096a0.0945.76E-020.17c0.169c0.169 a0.275 b
IL100.21c0.204c0.384c0.406c-0.043 5.98E-010.036 6.78E-01
M1 MacrophageINOS (NOS2)-0.196c-0.196c0.0354.75E-010.0612.36E-010.049 5.50E-010.082 3.39E-01
IRF50.216c0.219c0.108a0.0937.03E-020.040 6.26E-010.094 2.74E-01
COX2 (PTGS2)0.0847.40E-020.0394.31E-010.186c0.183c0.198 a0.254 b
M2 MacrophageCD1630.187c0.168c0.395c0.397c0.155 5.51E-020.213 a
VSIG40.18c0.158b0.401c0.421c0.018 8.25E-010.101 2.39E-01
MS4A4A0.221c0.204c0.421c0.431c0.060 4.58E-010.166 5.21E-02
NeutrophilsCD66B (CEACAM8)-0.0246.15E-01-0.0137.98E-010.0295.57E-010.0345.08E-010.033 6.87E-010.044 6.11E-01
CD11B (ITGAM)0.136b0.13b0.392c0.392c0.233 b0.319 c
CCR70.17c0.16b0.322c0.325c0.226 b0.254 b
Natural killer cellKIR2DL1-0.0246.08E-01-0.0572.51E-010.143b0.145b-0.025 7.62E-01-0.027 7.52E-01
KIR2DL3-0.0761.06E-01-0.0916.78E-020.0945.45E-020.0831.07E-01-0.022 7.88E-01-0.052 5.48E-01
KIR2DL4-0.0721.23E-01-0.11a0.0059.25E-010.0039.61E-01-0.009 9.11E-010.009 9.13E-01
KIR3DL1-0.0492.92E-01-0.0731.40E-010.142b0.127a0.042 6.06E-010.018 8.34E-01
KIR3DL2-0.018.31E-01-0.0632.04E-010.146b0.147b-0.086 2.93E-01-0.060 4.86E-01
KIR3DL3-0.0866.63E-02-0.0936.04E-02-0.0781.12E-01-0.0642.16E-01-0.118 1.48E-01-0.107 2.12E-01
KIR2DS4-0.0157.48E-01-0.0265.99E-010.0513.03E-010.0443.95E-01-0.001 9.88E-010.003 9.72E-01
Dendritic cellHLA-DPB10.0512.73E-010.0246.27E-010.287c0.291c0.032 6.91E-010.108 2.08E-01
HLA-DQB10.0562.29E-010.0374.55E-010.152b0.153b0.152 6.11E-020.234 b
HLA-DRA0.125b0.103a0.268c0.27c-0.049 5.51E-010.014 8.73E-01
HLA-DPA10.16c0.142b0.255c0.256c0.032 6.91E-010.108 2.08E-01
BDCA-1 (CD1C)0.29c0.291c0.303c0.302c-0.030 7.10E-010.025 7.70E-01
BDCA-4 (NRP1)0.348c0.37c0.523c0.52c0.376 c0.462 c
CD11c (ITGAX)0.156c0.15b0.341c0.348c0.081 3.19E-010.099 2.49E-01
Th1T-bet (TBX21)0.0691.39E-010.062.27E-010.266c0.264c0.237 b0.258 b
STAT40.159c0.148b0.301c0.294c-0.091 2.63E-01-0.043 6.18E-01
STAT10.197c0.182c0.189c0.177c0.078 3.38E-010.075 3.84E-01
IFN-γ (IFNG)0.0236.28E-010.0098.53E-010.098a0.0917.73E-020.120 1.40E-010.130 1.30E-01
TNF-α (TNF)0.118a0.098a0.104a0.0711.67E-010.022 7.83E-010.026 7.67E-01
Th2GATA30.176c0.183c0.305c0.304c0.125 1.24E-010.143 9.67E-02
STAT60.0068.92E-010.018.44E-010.224c0.219c0.289 c0.353 c
STAT5A0.155c0.172c0.431c0.426c0.071 3.81E-010.104 2.24E-01
IL130.124b0.099a0.151b0.153b0.021 7.93E-010.029 7.39E-01
TfhBCL60.145b0.143b0.388c0.367c0.238 b0.232 b
IL210.0741.13E-010.062.31E-010.133b0.12a0.023 7.73E-01-0.026 7.67E-01
Th17STAT30.318c0.327c0.426c0.411c0.404 c0.394 c
IL17A0.0552.42E-010.0572.51E-01-0.124a-0.133b-0.077 3.42E-01-0.082 3.42E-01
TregFOXP30.218c0.214c0.224c0.223c0.065 4.24E-010.073 3.98E-01
CCR80.317c0.327c0.341c0.336c0.052 5.26E-010.082 3.38E-01
STAT5B0.401c0.413c0.499c0.491c0.218 b0.179 a
TGFβ (TGFB1)0.114a0.1063.28E-020.418c0.406c0.325 c0.387 c
T cell (exhausted)PD1 (PDCD1)-0.0167.28E-01-0.053.16E-010.205c0.202c0.085 2.96E-010.132 1.23E-01
CTLA40.1a0.0926.43E-020.17c0.164b0.030 7.12E-010.060 4.89E-01
LAG3-0.0019.91E-01-0.0414.04E-010.202c0.196c0.116 1.52E-010.126 1.42E-01
TIM-3 (HAVCR2)0.223c0.22c0.38c0.391c0.046 5.76E-010.106 2.16E-01
GZMB0.0285.53E-010.0078.89E-010.134b0.132b-0.009 9.15E-010.043 6.20E-01